Alpa Laboratories Limited

₹55.93As of Sun 8 Nov 2026, 12:00 UTC
NSE:ALPAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 2.95%
Div yield —
ROE 8.38%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.98
PE TTM 26.50
TSR TTM (38.92%)
Mkt cap ₹1.177B
ROIC (4.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹72
28.35%
(83.91%)
Hold 7|3|1|11|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.02
0.99
1.05
1.07
0.07%
0.55%
4.67%
4.50%
Revenue₹M
150.7
154.2
149.8
148.7
9.73%
12.22%
4.34%
1.38%
Peers (US$12.08M)
Cap (US$)
PE
13.93M
18.09x
12.25M
4.268x
Capital
TTM
5Y
10Y
Leveragex
1.114
0.038
0.040
EBIT/Intx
6.606
0.041
0.040
Own earn%
(43.77)
18.67
(5.15)
Sh yield%
31.21
40.21
41.56
Owners
Insiders/Inst%
12.95
71.08
Short interest%
4.66
SBC / revenue%
3.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
4–11
$1 testx
0.0
Incr. ROIC%
9